Comparative Investigation of Intravenously Administered Omnipaque and Isovue: Effects on Serum Creatinine Concentration in Outpatients

NACompletedINTERVENTIONAL
Enrollment

413

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2012

Conditions
Kidney Disease
Interventions
PROCEDURE

Blood work

Prior to having the clinically scheduled CT examination the subject will have blood work drawn. This blood work will give the investigators a baseline value of the basic kidney function of the subject. They will then have blood work done again at 2 days and again at 3 days following the CT examination. Some patients, based on their blood work obtained at 2 and 3 days after the CT examination, will be asked to have blood work performed at 7 days after their CT examination.

Trial Locations (1)

48109

University of Michigan Hospital, Ann Arbor

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

GE Healthcare

INDUSTRY

lead

University of Michigan

OTHER

NCT00734357 - Comparative Investigation of Intravenously Administered Omnipaque and Isovue: Effects on Serum Creatinine Concentration in Outpatients | Biotech Hunter | Biotech Hunter